Benzothiadiazole-containing large conjugated receptor derivative, nanoparticle fluorescent probe and preparation method and application thereof
The invention discloses a benzothiadiazole-containing large conjugated receptor derivative, a nanoparticle fluorescent probe as well as a preparation method and application of the benzothiadiazole-containing large conjugated receptor derivative. The structural formula of the benzothiadiazole-containing large conjugated receptor derivative is # imgabs0 #. The nanoparticle fluorescent probe provided by the invention comprises the benzothiadiazole-containing large conjugated receptor derivative and an amphiphilic polymer, wherein the structural formula of the benzothiadiazole-containing large conjugated receptor derivative is # imgabs0 #; the amphiphilic polymer is coated with a large conjugated receptor derivative containing benzothiadiazole. The compound and the nanoparticle fluorescent probe provided by the invention integrate high thermal conversion coefficient, considerable light absorption capability and high fluorescence quantum yield, and have higher photo-thermal conversion capability and photoluminescence intensity compared with the existing NIR-II region fluorescent probe..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Europäisches Patentamt - (2023) vom: 15. Sept. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
TANG BENZHONG [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-09-15, Last update posted on www.tib.eu: 2023-12-19, Last updated: 2023-12-22 |
|---|
| Patentnummer: |
CN116751215 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA018714706 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA018714706 | ||
| 003 | DE-627 | ||
| 005 | 20231222112551.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231215s2023 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA018714706 | ||
| 035 | |a (EPA)CN116751215 | ||
| 035 | |a (EPA)87946700 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a TANG BENZHONG |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Benzothiadiazole-containing large conjugated receptor derivative, nanoparticle fluorescent probe and preparation method and application thereof |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2023-09-15, Last update posted on www.tib.eu: 2023-12-19, Last updated: 2023-12-22 | ||
| 520 | |a The invention discloses a benzothiadiazole-containing large conjugated receptor derivative, a nanoparticle fluorescent probe as well as a preparation method and application of the benzothiadiazole-containing large conjugated receptor derivative. The structural formula of the benzothiadiazole-containing large conjugated receptor derivative is # imgabs0 #. The nanoparticle fluorescent probe provided by the invention comprises the benzothiadiazole-containing large conjugated receptor derivative and an amphiphilic polymer, wherein the structural formula of the benzothiadiazole-containing large conjugated receptor derivative is # imgabs0 #; the amphiphilic polymer is coated with a large conjugated receptor derivative containing benzothiadiazole. The compound and the nanoparticle fluorescent probe provided by the invention integrate high thermal conversion coefficient, considerable light absorption capability and high fluorescence quantum yield, and have higher photo-thermal conversion capability and photoluminescence intensity compared with the existing NIR-II region fluorescent probe. | ||
| 650 | 4 | |a C07D: Heterocyclic compounds (macromolecular compounds c08) | |
| 650 | 4 | |a C09K: Materials for applications not otherwise provided for; applications of materials not otherwise provided for | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a phy | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a B82Y: Specific uses or applications of nanostructures; measurement or analysis of nanostructures; manufacture or treatment of nanostructures | |
| 650 | 4 | |a cet | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a ZHOU DAMING |4 aut | |
| 700 | 0 | |a QIN ANJUN |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 15. Sept. |
| 773 | 1 | 8 | |g year:2023 |g day:15 |g month:09 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/87946700/publication/CN116751215A1?q=CN116751215 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 936 | u | w | |j 2023 |b 15 |c 09 |
| 951 | |a AR | ||
| 952 | |j 2023 |b 15 |c 09 | ||